|
|
Other links at Articles > Pharmacists |
| 1. |
First-Time Generic Approvals: Procardia XL, Estrostep FE, Estrostep
|
|
|
The FDA has approved first-time generic formulations for nifedipine extended-release tablets in 90-mg strength; norethindrone acetate and ethinyl estradiol tablets (28-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths; and norethindrone acetate and ethinyl estradiol tablets (21-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths. Medscape Medical News
|
| 4. |
Infliximab for Rheumatoid Arthritis Seen Safe in Japanese Patients
|
|
|
Results of a post-marketing surveillance study in Japan provide a "real world" picture of the incidence of adverse reactions associated with infliximab therapy for rheumatoid arthritis (RA), according to a Japanese research team. They conclude that the safety profile is acceptable. Reuters Health Information
|
| 5. |
Larynx-Preserving Chemoradiotherapy Yields Good Voice Outcomes
|
|
|
Voice outcomes are better after chemoradiotherapy (chemo-RT) than after total laryngectomy in patients with advanced laryngopharyngeal cancer, according to a report in the February issue of the International Journal of Radiation Oncology*Biology*Physics. Reuters Health Information
|
|
|